---
title: "600196.SH (600196.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/600196.SH/news.md"
symbol: "600196.SH"
name: "600196.SH"
parent: "https://longbridge.com/en/quote/600196.SH.md"
datetime: "2026-05-20T05:21:29.407Z"
locales:
  - [en](https://longbridge.com/en/quote/600196.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/600196.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/600196.SH/news.md)
---

# 600196.SH (600196.SH) — Related News

### [Health insurance annualized returns exceed 10%? Regulators intervene to correct "financialization"](https://longbridge.com/en/news/286604167.md)
*2026-05-15T18:51:08.000Z*
> In recent years, regulatory authorities have rectified health insurance products, requiring the delisting of certain hig

### [FOSUN PHARMA Increases Investment in Oral Alzheimer's Drug, Phase III Data Expected Within the Year](https://longbridge.com/en/news/286426372.md)
*2026-05-14T13:35:59.000Z*
> FOSUN PHARMA plans to increase its investment in an oral drug for Alzheimer's disease. Phase III clinical data is expect

### [FOSUN PHARMA's "Smart Deal": Locking in $60 million for AR1001 with an imagination space exceeding $2.5 billion](https://longbridge.com/en/news/286393170.md)
*2026-05-14T09:48:05.000Z*
> FOSUN PHARMA has reached a $60 million agreement with South Korea's AriBio to secure the long-term development potential

### [FOSUN PHARMA has obtained global exclusive rights for an oral new drug for Alzheimer's disease](https://longbridge.com/en/news/286381329.md)
*2026-05-14T08:04:11.000Z*
> FOSUN PHARMA has signed a global exclusive option agreement with AriBio, acquiring the development, registration, produc

### [FOSUN PHARMA obtains exclusive commercialization option for Alzheimer's treatment, receiving at least nearly 1.9 billion yuan](https://longbridge.com/en/news/286333998.md)
*2026-05-14T00:22:00.000Z*
> FOSUN PHARMA announced that its holding subsidiary has obtained an exclusive commercialization option granted by AriBio,

### [Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease](https://longbridge.com/en/news/286331957.md)
*2026-05-14T00:00:00.000Z*
> Fosun Pharma and AriBio have signed an exclusive global option agreement for AR1001, a drug candidate for Alzheimer's di

### [FOSUN PHARMA: The drug registration application for Peach Blossom Four Substance Soup Granules has been accepted](https://longbridge.com/en/news/286252389.md)
*2026-05-13T11:33:02.000Z*
> The registration application for the Peach Blossom Four Substance Soup granules from FOSUN PHARMA's subsidiary Hebei Wan